Skip to Content
Merck
CN

222801

4-Nitrobenzyl chloroformate

97%, for peptide synthesis

Synonym(s):

(4-Nitrophenyl)methyl carbonochloridate, (4-Nitrophenyl)methyl chloroformate, 4-Nitrobenzyloxycarbonyl chloride, p-Nitrobenzyloxycarbonyl chloride, p-nitrobenzyl chloroformate

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Linear Formula:
ClCO2CH2C6H4NO2
CAS Number:
Molecular Weight:
215.59
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352101
EC Number:
224-708-6
MDL number:
Beilstein/REAXYS Number:
912446
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

4-Nitrobenzyl chloroformate, 97%

InChI key

MHSGOABISYIYKP-UHFFFAOYSA-N

InChI

1S/C8H6ClNO4/c9-8(11)14-5-6-1-3-7(4-2-6)10(12)13/h1-4H,5H2

SMILES string

[O-][N+](=O)c1ccc(COC(Cl)=O)cc1

assay

97%

reaction suitability

reaction type: Carbonylations

mp

32-34 °C (lit.)

application(s)

peptide synthesis

functional group

chloro
nitro

storage temp.

2-8°C

Quality Level

Looking for similar products? Visit Product Comparison Guide

pictograms

CorrosionExclamation mark

signalword

Danger

hcodes

Hazard Classifications

Eye Dam. 1 - Skin Corr. 1B - STOT SE 3

target_organs

Respiratory system

Storage Class

8A - Combustible corrosive hazardous materials

wgk

WGK 3

ppe

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Eun Hyang Jang et al.
International journal of pharmaceutics, 580, 119237-119237 (2020-03-24)
Hypoxia is a characteristic feature of various ischemic diseases, including cancer. This study describes the development of glycol chitosan nanoparticles, hydrophobically modified with 4-nitrobenzyl chloroformate and folic acid (FA), that can specifically release drugs under hypoxic conditions. This hypoxia-responsive glycol

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service